About Us

RapidDx is developing an inexpensive, state-of-the-art, handheld diagnostic device designed to assist clinicians in the precise detection of dementia diseases, particularly Alzheimer’s and Parkinson’s. RapidDx’s patented device, the RAD, aims to harvest, process and analyze saliva to identify biomarkers present using advanced lateral flow technology and provide clinicians with positive or negative results.

Our groundbreaking work is built upon the pioneering research of renowned scientists Dr. Balwant Rai and Dr. Paul Slowey. RapidDx has accumulated an impressive portfolio of intellectual property, including granted patents for our “lab in your hand” device, for Alzheimer’s and Parkinson’s detection. Patent applications are in an advanced stage of prosecution for additional patents for Alzheimer’s and Parkinson’s, as well as for traumatic brain injury (TBI), especially concussion.

We have successfully licensed the manufacturing and distribution of our concussion detection technology to a US-based company, ensuring that we retain full ownership and control over intellectual property and ongoing development.

At RapidDx, we are dedicated to enhancing the capabilities of healthcare providers through innovative diagnostic solutions, ultimately improving patient outcomes and quality of life.